O

    Organogenesis Holdings Inc (ORGO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.72
    -0.02 (-1.15%)

    Market Cap: $221.32M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(20/30)
    Avg Surprise
    +50.51%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.17
    Range$-0.17 - $-0.17
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.12+29.4%
    60d ago$-0.13+26.5%
    30d ago$-0.13+26.5%
    7d ago$-0.13+26.5%
    Current$-0.17
    Revenue Consensus
    $52M
    Range$52M - $53M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.56
    Range$-0.57 - $-0.56
    2 analysts
    Revenue Consensus
    $46M
    Range$42M - $51M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.56---
    Sep 26EST
    		-$-0.17---
    Jun 26
    Reported Aug 6
    		$-0.71$-0.35-102.86%Miss-688.9%
    Mar 26
    Reported May 7
    		$-0.34$-0.29-17.24%Miss-209.1%
    Dec 25
    Reported Feb 26
    		$0.31$0.22+43.72%Beat+368.3%
    Sep 25
    Reported Nov 6
    		$0.18$0.07+157.14%Beat+80.0%
    Jun 25
    Reported Aug 7
    		$-0.09$-0.01-800.00%Miss-325.0%
    Mar 25
    Reported May 8
    		$-0.11$-0.03-266.67%Miss-1000.0%
    Dec 24
    Reported Feb 27
    		$0.07$0.02+231.00%Beat+1639.5%
    Sep 24
    Reported Nov 12
    		$0.10$0.02+400.00%Beat+150.0%
    Jun 24
    Reported Aug 8
    		$0.04$0.02+100.00%Beat-20.0%
    Mar 24
    Reported May 9
    		$-0.01N/A+66.67%Beat+0.0%
    Dec 23
    Reported Feb 29
    		$-0.00N/A-143.00%Miss-107.2%
    Sep 23
    Reported Nov 9
    		$0.04$0.01+300.00%Beat+0.0%
    Jun 23
    Reported Aug 9
    		$0.05$0.04+25.00%Beat-28.6%
    Mar 23
    Reported May 10
    		$-0.01$-0.02+50.00%Beat-209.9%
    Dec 22
    Reported Mar 1
    		$0.06$0.05+20.00%Beat-84.6%
    Sep 22
    Reported Nov 9
    		$0.04$0.07-42.86%Miss-66.7%
    Jun 22
    Reported Aug 9
    		$0.07$0.08-12.50%Miss-50.0%
    Mar 22
    Reported May 10
    		$0.01N/A-84.83%Miss-88.6%
    Dec 21
    Reported Mar 1
    		$0.39$0.08+387.50%Beat+160.0%
    Sep 21
    Reported Nov 9
    		$0.12$0.06+100.00%Beat-36.8%
    Jun 21
    Reported Aug 9
    		$0.14$0.06+133.33%Beat+380.0%
    Mar 21
    Reported May 10
    		$0.08$-0.02+500.00%Beat+150.0%
    Dec 20
    Reported Mar 16
    		$0.15$0.14+7.14%Beat+475.0%
    Sep 20
    Reported Nov 9
    		$0.19$-0.07+371.43%Beat+258.3%
    Jun 20
    Reported Aug 10
    		$-0.05N/A+80.77%Beat+54.5%
    Mar 20
    Reported May 11
    		$-0.16$-0.13-23.08%Miss-6.7%
    Dec 19
    Reported Mar 9
    		$-0.04N/A+55.56%Beat+66.7%
    Sep 19
    Reported Nov 12
    		$-0.12$-0.12+0.00%Beat-124.0%
    Jun 19
    Reported Aug 9
    		$-0.11$-0.13+15.38%Beat-375.0%
    Mar 19
    Reported May 10
    		$-0.15$-0.11-36.36%Miss-1400.0%
    Dec 18
    Reported Mar 18
    		$-0.12N/AN/ABeat+7.7%
    Sep 18
    Reported Nov 9
    		$0.50N/AN/ABeat+266.7%
    Jun 18
    Reported Aug 7
    		$0.04N/AN/ABeat+200.0%
    Mar 18
    Reported May 10
    		$-0.01N/AN/ABeat-150.0%
    Dec 17
    Reported Mar 14
    		$-0.13N/AN/ABeat-477.8%
    Sep 17
    Reported Nov 14
    		$-0.30N/AN/ABeat-
    Jun 17
    Reported Aug 11
    		$-0.04N/AN/ABeat-
    Mar 17
    Reported May 12
    		$0.02N/AN/ABeat-
    Dec 16
    Reported Mar 28
    		$-0.02N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-3.07EV/EBITDA10.58x
    Price/FCF10.62xFCF Yield9.42%
    Profitability
    Profit Margin-18.40%Operating Margin-119.30%
    ROE-25.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-19.59x
    Current Ratio3.52xQuick Ratio3.00x
    Trading Statistics
    Beta1.32Avg Volume894.79K
    52-Week High$7.0852-Week Low$1.54

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.77
    SMA 20$1.88
    SMA 50$2.23
    SMA 200$3.19
    EMA 10$1.78
    EMA 20$1.89
    EMA 50$2.13
    EMA 200$2.88

    MACD

    Line: -0.16Signal: -0.16Hist: 0.01

    ADX

    ADX: 32.3+DI: 14.8-DI: 33.9

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down36.0
    PSAR$1.80

    Bollinger Bands

    Upper Band$2.33
    Lower Band$1.42
    %B Position4833%(Upper)
    Band Width0.33

    RSI (14-Day)

    Neutral
    34.5

    Momentum Oscillators

    Stoch %K23.7
    Stoch %D28.5
    Williams %R-79.3
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)-68.8
    MFI (14d)32.1

    Volatility Measures

    ATR (14d)$0.12(7.1%)
    StdDev (20d)0.23
    Hist Vol95.5%(High)

    Volume Flow

    VWAP$1.71
    OBV82.5M
    AD Line13.6M
    CMF (20d)0.209

    Volume Metrics

    Avg Vol (20d)900.5K
    Vol Ratio0.7x
    VWMA (20d)$1.88

    Pivot Points

    R3$1.81
    R2$1.78
    R1$1.76
    Pivot Point$1.73
    S1$1.71
    S2$1.68
    S3$1.66

    Advanced Oscillators

    TSI-31.87
    Ultimate Osc49.3
    KST-250.66

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$43.76M$37.23M$225.61M$150.86M$101.00M$86.69M$126.66M$115.18M$130.23M$109.98M$99.65M$108.53M
    Cost of Revenue$23.67M$25.77M$49.92M$36.25M$27.63M$23.72M$31.05M$26.80M$29.20M$28.70M$27.77M$25.79M
    Gross Profit$20.08M$11.46M$175.69M$114.61M$73.38M$62.97M$95.61M$88.38M$101.04M$81.28M$71.88M$82.74M
    Operating Expenses$71.07M$80.35M$112.40M$93.89M$85.95M$89.72M$85.39M$82.14M$114.93M$85.13M$73.15M$74.69M
    R&D$18.30M$15.16M$10.29M$13.22M$10.39M$10.64M$11.53M$10.34M$15.59M$12.81M$11.77M$10.47M
    SG&A$53.97M$65.19M$100.17M$79.74M$73.81M$72.51M$73.86M$71.80M$76.54M$72.32M$61.38M$64.22M
    Operating Income$-50,992,000$-68,891,000$63.29M$20.73M$-12,576,000$-26,746,000$10.22M$6.24M$-13,892,000$-3,852,000$-1,269,000$8.05M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$-138,000$-380,000$-236,000$-415,000$-669,000$-961,000$-61,000$471,000$620,000$514,000$503,000$444,000
    Income Before Tax$-50,880,000$-68,473,000$63.43M$21.16M$-11,834,000$-25,783,000$10.25M$5.82M$-14,540,000$-4,343,000$-1,797,000$7.64M
    Income Tax Expense$45.39M$-15,317,000$19.73M$-407,000$-2,442,000$-6,940,000$2.58M$-6,508,000$2.50M$-2,243,000$-1,228,000$4.47M
    Net Income$-96,267,000$-53,156,000$43.70M$21.57M$-9,392,000$-18,843,000$7.67M$12.33M$-17,043,000$-2,100,000$-569,000$3.17M
    EBITDA$-46,917,000$-58,971,000$68.06M$25.62M$-7,928,000$-22,458,000$14.64M$10.70M$-9,720,000$144,000$2.92M$11.85M
    EBIT$-51,018,000$-68,853,000$63.19M$20.75M$-12,503,000$-26,744,000$10.19M$6.29M$-13,920,000$-3,829,000$-1,294,000$8.08M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ORGO

    Government Contracts

    Gov Obligations (TTM)
    $109996
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    25
    New Awards (TTM)
    25
    Avg Remaining Term
    N/A

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    SPE2D625F2XPGDepartment of DefenseDefense Logistics Agency$17820Sep 9, 2025
    SPE2D625F0RYGDepartment of DefenseDefense Logistics Agency$17820Aug 11, 2025
    SPE2D625F1CTUDepartment of DefenseDefense Logistics Agency$11580Aug 15, 2025
    SPE2D626F310JDepartment of DefenseDefense Logistics Agency$8500Nov 19, 2025
    SPE2D626F5690Department of DefenseDefense Logistics Agency$8500Oct 28, 2025
    SPE2D625F0CKSDepartment of DefenseDefense Logistics Agency$8500Aug 4, 2025
    SPE2D625F0RXUDepartment of DefenseDefense Logistics Agency$5790Aug 11, 2025
    SPE2D626F0015Department of DefenseDefense Logistics Agency$3400Oct 1, 2025
    SPE2D626F146HDepartment of DefenseDefense Logistics Agency$2480Nov 13, 2025
    SPE2D626F2025Department of DefenseDefense Logistics Agency$2480Oct 15, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    ORGO | Organogenesis Holdings Inc. Class Financials - Revenue Breakdown

    This article provides a detailed financial breakdown for Organogenesis Holdings Inc. (ORGO), focusing on its revenue segmentation. It also covers various other financial data points such as insider trading, institutional holdings, analyst ratings, and executive compensation, while noting the absence of specific revenue-by-segment or geography data. The company is described as a regenerative medicine firm specializing in advanced wound care and surgical markets.

    Quiver Quantitative•8/23/26•
    Neutral

    Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ

    Organogenesis Holdings, Inc. Class A (MUN:2PQ) generated €479.37 million in revenue last year, primarily from its Advanced Wound Care segment, which contributed €452.31 million. The majority of this revenue, €479.37 million, originated from the United States market. These figures represent an increase from the previous year's performance.

    TradingView•8/11/26•
    Neutral

    Organogenesis (Nasdaq: ORGO) sets up $75M at-the-market stock sale

    Organogenesis Holdings Inc. has established an at-the-market sales agreement with BTIG, LLC and Citizens JMP Securities, LLC to offer and sell up to $75 million of its Class A common stock. Sales will occur from time to time through the agents on the Nasdaq Capital Market, with Organogenesis paying up to a 3.0% commission on gross sales. The offering is made under a previously filed shelf registration statement on Form S-3.

    Stock Titan•8/7/26•
    Neutral

    Organogenesis Holdings, Inc. Class A Revenue Breakdown – LS:A2PA31

    Organogenesis Holdings, Inc. Class A (A2PA31) generated 479.37 million EUR in revenue last year, primarily from its Advanced Wound Care segment, which contributed 452.31 million EUR. The United States was the company's largest regional contributor, accounting for all of its revenue. These figures highlight the company's strong performance in its core segment and primary market.

    TradingView•8/6/26•
    Neutral

    Organogenesis Holdings, Inc. Class A Revenue Breakdown – LSX:A2PA31

    Organogenesis Holdings, Inc. Class A (LSX:A2PA31) generated 479.37 million EUR in revenue last year. The Advanced Wound Care segment was the top-performing segment, contributing 452.31 million EUR, an increase from 438.21 million EUR the prior year. The United States was the primary geographic contributor, accounting for all of the company's revenue.

    TradingView•8/3/26•
    Somewhat-Bullish

    Frequently Asked Questions About ORGO

    Does ORGO pay dividends?
    Organogenesis Holdings Inc (ORGO) does not currently pay a regular dividend.
    What is ORGO's market cap?
    Organogenesis Holdings Inc (ORGO) has a market capitalization of $221.32M with a current stock price of $1.72.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In